Patient Temperature Management Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Patient Temperature Management Market size was valued at USD 3.4 billion in 2023 and is estimated to grow at 5.6% CAGR from 2024 to 2032. Increasing prevalence of chronic conditions such as cancer, infectious diseases, and cardiovascular disorders are among the significant driving factors for the market growth. Cancer is a leading cause of morbidity and mortality worldwide, and surgical resection is a common treatment modality for many cancer types.
For instance, according to the International Agency for Research on Cancer (IARC), in 2022, there were 20 million new cancer cases and 9.7 million cancer deaths worldwide. Patients undergoing cancer surgeries, such as mastectomy, abdominal surgeries, and tumor resections, are at risk of perioperative hypothermia due to prolonged anesthesia exposure and intraoperative exposure to cold environments.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Patient Temperature Management Market size in 2023: | USD 3.4 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 5.6 |
2023 Value Projection: | USD 5.6 Billion |
Historical Data for: | 2021 - 2023 |
No of Pages: | 110 |
Tables, Charts & Figures: | 182 |
Segments Covered: | Product Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Further, patient temperature management devices, such as forced-air warming blankets and intravascular warming systems, are essential for maintaining normothermia during cancer surgeries, reducing the risk of surgical complications, improving wound healing, and enhancing patient recovery outcomes.
Patient temperature management refers to the process of regulating a patient's body temperature within a specific range to maintain physiological homeostasis during medical procedures, surgery, or critical care situations. This management typically involves the use of temperature management systems to adjust the patient's temperature, ensuring that it remains within a safe and optimal range to promote recovery, reduce complications, and improve overall patient outcomes.
The latest technological advancements in patient temperature management systems include non-invasive methods and integration with other healthcare systems. These advancements aim to improve the efficiency and user-friendliness of temperature management systems.
Based on product type, the market is categorized into patient warming system and patient cooling system. The patient warming system segment dominates the market with a revenue of around USD 2.6 billion in 2023.
Based on application, the patient temperature management market is categorized into cardiology, orthopedics, neurology, and other applications. The cardiology segment dominates the market with a revenue of around USD 1.2 billion in 2023.
Based on end-use, the patient temperature management market is categorized into hospitals, ambulatory surgical centers, neonatal care units, specialized clinics, and other end-users. The hospitals segment held a leading market share in the market with a revenue of around USD 1 billion in 2023.
North America patient temperature management market accounted for USD 1.3 billion in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
The U.S. held a dominant position in the patient temperature management market, with a revenue of USD 1.2 billion in 2023.
Japan patient temperature management industry is anticipated to witness substantial growth during 2024-2032.
China exhibits a high growth potential in the patient temperature management market over the forecast period.
Europe healthcare systems prioritize patient safety and outcomes. Hospitals, ambulatory surgical centers, and other healthcare facilities are investing in advanced patient warming and cooling systems to reduce complications and improve clinical outcomes, that is anticipated to boost the Europe patient temperature management market growth.
The patient temperature management industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel systems with improved efficiency and cost-effectiveness are key market strategies for the manufacturers, driving competition and innovation in the patient temperature management industry. This emphasis on innovation aims to address evolving clinical needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for advanced patient temperature management systems.
Some of the eminent market participants operating in the patient temperature management industry include:
Market, By Product Type
By Application
By End-use
The above information is provided for the following regions and countries:
The market size of patient temperature management reached USD 3.4 billion in 2023 and is set to grow at 5.6% CAGR from 2024 to 2032, owing to the increasing prevalence of chronic conditions, such as cancer, infectious diseases, and cardiovascular disorders.
The cardiology segment generated USD 1.2 billion in 2023, due to the prevalence of cardiovascular diseases (CVDs) and the growing need for cardiovascular interventions and surgeries.
North America market size was USD 1.3 billion in 2023, attributed to favorable reimbursement scenarios and increasing healthcare expenditure.
3M Company, Atom Medical Corp., Baxter International, Inc., Becton, Dickinson and Company, Cincinnati Sub-Zero Products, LLC, Dragerwerk AG & Co. KGaA, GENTHERM, Medtronic plc., ICU Medical, Inc., Stryker Corporation and Zoll Medical Corporation.